A comprehensive view of Infections & Infectious Diseases. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
BD accelerates diagnostic testing with BD Veritorâ„¢ Plus System; tests for COVID-19, Influenza A+B, RSV, and Group A Strep provide results in 15 minutes amid respiratory illness challenges
Published:
July 26, 2024
by Industry Intelligence Inc.
|
CDC researchers focus on poliovirus transmission from 2017 to 2024 in Somalia; significant progress made since the Global Polio Eradication Initiative in 1988
Published:
July 26, 2024
by Vaccine Daily
|
HHS broadens emergency declaration to include pandemic-potential viruses like H5N1 bird flu; the amendment allows FDA to extend medical product expiration dates and issue emergency use authorizations
Published:
July 23, 2024
by The American Hospital Association (AHA)
|
Merck reports successful Phase 2b/3 results for clesrovimab in preventing RSV in infants; clesrovimab met primary safety and efficacy endpoints, reducing respiratory infections through Day 150
Published:
July 23, 2024
by Merck & Co. Inc.
|
U.S. Patent and Trademark Office Releases Symrise AG's Patent Application for Compositions with Virucidal and/or Antiviral Activity
Published:
July 22, 2024
by Chemical Patent News
|
Ask us about our Government & Public Policy market view
Trending Chart
Interactive chart with headline count